Dow Up 0.71% Nasdaq Down 0.32%

Epizyme, Inc. (EPZM)

-NasdaqGS
26.98 Up 0.75(2.86%) 11:24AM EDT - Nasdaq Real Time Price
Prev Close:26.23
Open:26.12
Bid:27.10 x 100
Ask:27.23 x 100
1y Target Est:43.33
Beta:3.513
Next Earnings Date:30-Oct-14EPZM Earnings announcement
Day's Range:26.12 - 27.23
52wk Range:18.10 - 42.00
Volume:76,237
Avg Vol (3m):343,828
Market Cap:906.07M
P/E (ttm):N/A
EPS (ttm):-0.46
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for EPZM

Comparison

Symbol% ChgMkt Cap
EPZMUp 2.86%906.07M
GSKDown 0.20%108.16B
NVSUp 0.35%221.93B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.60
Quarterly EPS Est (Sep-14) :-0.55
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback